Glycosyltransferase Inhibitor-based Cell Surface Metabolic Glycoengineering Service

Applications of Glycosyltransferase Inhibitor-based Cell Surface Metabolic Glycoengineering (MGE)

Glycosyltransferases are a class of enzymes responsible for the transfer of glycan groups to receptor molecules, resulting in glycan modification. Glycosyltransferase inhibitors, on the other hand, are a class of chemicals that inhibit the activity of glycosyltransferases. These inhibitors reduce the catalytic activity of the enzymes, thereby regulating glycan modifications. The glycosyltransferase inhibitor-based cell surface MGE is utilized in a variety of applications. For example, in vaccine development, these inhibitors interfere with the specific glycosylation reaction by preventing the enzymes from binding to the substrate, thereby inhibiting the specific glycosylation process. This removes unnatural sugar groups from the vaccine, making the vaccine antigen more readily recognized by the immune system of the body. In biomolecule detection, when a specific biomolecule binds to a ligand that is glycosylated, the corresponding signal change can be detected by the sensor, thus realizing highly sensitive detection of the target biomolecule.

Fig.1 The display of defined glycans on the cell surface reveals the function of glycans and determines cell fate. (Nischan & Kohler, 2016)

Glycosyltransferase Inhibitor-based Cell Surface MGE Service at CD BioGlyco

CD BioGlyco provides clients with efficient Cell Surface MGE services based on our reliable Glycoengineering Platform, including the development and custom solutions for glycosyltransferase inhibitor-based cell surface MGE service. The details of our services are as follows:

• Raw material preparation
  We select the cells and perform cell culture to bring them to the appropriate growth state and prepare the appropriate concentration of inhibitor solution.
• Process of modification
  We add the inhibitor to the cell culture medium to bring it into contact with the cells. Sufficient time is generally required to ensure full action of the inhibitor. Subsequently, we measure the activity of enzymes using appropriate methods such as enzyme activity assay kits. Finally, we analyze and characterize changes in the type and level of the glycan modification.
• Interpretation and optimization of results
  We analyze the data based on the experimental results and optimize the experimental conditions and operations.

Fig.2 Workflow of glycosyltransferase inhibitor-based cell surface MGE. (CD BioGlyco)

Applications

• This technology can be widely used to produce high-purity recombinant proteins and glyco-drugs.
• This technology is applied to target the expression of proteins, alter their stability and activity, and modulate the interaction between proteins and some molecules.
• It has a wide range of applications in immune cell detection, enabling specific recognition of immune cells.

Advantages of Us

• Glycosyltransferase inhibitors target and inhibit the activity of specific enzymes, thereby controlling the synthesis and translocation of intracellular substrate donors and achieving precise regulation of cell surface glycan modifications.
• With an experienced team and state-of-the-art facilities, we are committed to providing a full range of support and solutions to our clients.
• We will work with you to develop a customized glycoengineering program, designing the right experimental process for your research goals and needs.

CD BioGlyco is dedicated to providing a specialized glycosyltransferase inhibitor-based cell surface MGE service. We will obtain reliable results for enzyme activity analysis and glycan modification analysis with the help of advanced technology and equipment. Please feel free to contact us if you are interested in this service, and we look forward to cooperating with you!